Govt Invites Pharma Firms to Submit Data for Ceiling Price Review
New Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilizers, has invited pharmaceutical manufacturers to apply for revision of ceiling prices for eligible scheduled formulations. The move applies to drugs already listed under the National List of Essential Medicines (NLEM), 2022 and also present in NLEM 2015, in line with paragraph 18 of the Drugs (Prices Control) Order, 2013 (DPCO).
In its latest circular, the Department stated, “In accordance with the provisions of para 18(i) of Drugs (Prices Control) Order, 2013, the Department of Pharmaceuticals invites applications for revision of ceiling prices for the scheduled formulations as specified under NLEM, 2022 which were also included in NLEM, 2015.”
As per Para 18(i) of DPCO, 2013, “The Government may revise the ceiling price of scheduled formulations as specified under the First Schedule after the expiry of one year from the date of fixing the ceiling price of such scheduled formulations.”
This price revision process offers an opportunity for manufacturers to submit fresh data reflecting updated market dynamics. However, the scope is limited to those formulations which have already been under price control for over a year.
Manufacturers are instructed to apply only through the online portal, “Applications for revision of ceiling prices may be submitted only through Integrated Pharmaceutical Database Management System (IPDMS) portal at https://ipdms.gov.in in the prescribed Format.”
The notice further clarifies that, “Applications without supporting data shall not be considered.”
To view the official notice, click on the link below:
